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Abstract
Autosomal dominant (de novo) mutations in PBX1 are known to cause congenital
abnormalities of the kidney and urinary tract (CAKUT), with or without extra-renal
abnormalities. Using trio exome sequencing, we identified a PBX1 p.(Arg107Trp) muta-
tion in a deceased one-day-old neonate presenting with CAKUT, asplenia, and severe
bilateral diaphragmatic thinning and eventration. Further investigation by droplet digital
PCR revealed that the mutation had occurred post-zygotically in the father, with differ-
ent variant allele frequencies of the mosaic PBX1 mutation in blood (10%) and sperm
(20%). Interestingly, the father had subclinical hydronephrosis in childhood. With an
expected recurrence risk of one in five, chorionic villus sampling and prenatal diagnosis
for the PBX1 mutation identified recurrence in a subsequent pregnancy. The family
opted to continue the pregnancy and the second affected sibling was stillborn at
35 weeks, presenting with similar severe bilateral diaphragmatic eventration, micro-
splenia, and complete sex reversal (46, XY female). This study highlights the importance
of follow-up studies for presumed de novo and low-level mosaic variants and broadens
the phenotypic spectrum of developmental abnormalities caused by PBX1 mutations.
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1 | INTRODUCTION
Congenital anomalies of the kidney and urinary tract (CAKUT) refer to
inborn morphogenic defects of the renal system and urinary tract and
represent a broad spectrum of clinical manifestations. The large pheno-
typic heterogeneity of CAKUT ranges from subclinical abnormalities
present in the general population, to severe malformations which are
sometimes incompatible with life (Knoers & Renkema, 2019; Nicolaou,
Renkema, Bongers, Giles, & Knoers, 2015).
De novo mutations in PBX1 were first identified as a cause of
CAKUT in humans in 2017 (MIM: 617641) following earlier work dem-
onstrating renal hypoplasia, renal ectopia, and renal agenesis in
a Pbx1−/− mouse model (Heidet et al., 2017; Le Tanno et al., 2017;
Schnabel, Selleri, & Cleary, 2003; Slavotinek et al., 2017). The reported
heterozygous disease causing mutations in PBX1 include partial and
complete gene deletions, truncating, splice site and missense variants
(Figure S1). These de novo variants have been described in individuals
with renal hypoplasia/dysplasia and associated urinary tract abnormali-
ties, with a broad range of extra-renal abnormalities. These include
facial dysmorphism, and anatomic abnormalities of the ear, genitalia,
heart, and lung. Developmental delay/intellectual disability is common,
and growth restriction and hearing loss have also been reported
(Table S1; Alankarage et al., 2019; Eozenou et al., 2019; Heidet et al.,
2017; Kia, Sarafoglou, Mooganayakanakote Siddappa, & Roberts, 2019;
Riedhammer et al., 2017; Slavotinek et al., 2017; Sun et al., 2019; Le
Tanno et al., 2017). We present two cases of perinatal death, from inde-
pendent pregnancies in one family, with a recurrent disease-causing
mutation in PBX1 due to paternal mosaicism for the mutation.
2 | METHODS
2.1 | Patient consent and ethics approval
This study was performed in concordance with the declaration of Hel-
sinki. The family were referred to the clinical genetics unit for consid-
eration of an underlying genetic diagnosis following the first affected
pregnancy. The family were counseled and provided consent for
enrolment into the Genomic Autopsy Study (HREC/15/WCHN/35,
family study ID: PED043), a National Health and Medical Research
Council (NHMRC) funded study.
2.2 | Genomic analysis
Parents-proband trio whole exome sequencing (WES) was performed
on DNA isolated from whole blood. Exonic sequences were enriched
from genomic DNA using an Illumina exome capture (38 Mb target) and
sequenced at the Genomics Platform of the Broad Institute (Boston,
MA). Sequencing reads were aligned to the human reference genome
GRCh37/hg19 (BWA 0.7.12) and single nucleotide variants (SNVs) and
small insertions/deletions were called using GATK HaplotypeCaller
(package version 3.8.0). Copy number variants (CNVs) were detected
using an in-house (unpublished) algorithm. Data from 98 unrelated sam-
ples sequenced in the same batch were used to normalize read depth
signals before partitioning into bin sizes optimal for the exome capture.
Variant filtering was performed to select for rare protein altering vari-
ants (SNVs: gnomAD and in-house frequencies <1% for autosomal
recessive [AR] and <0.01% for autosomal dominant [AD], CNVs: no
reciprocal overlap with known benign CNVs ≥70%; Lek et al., 2016).
2.3 | Droplet digital PCR
Given the father's low-level mosaicism in blood, droplet digital PCR
(ddPCR) was performed on a sperm sample to define the recurrence
risk. The ddPCR assay for the PBX1 c.319C > T variant was ordered
from Thermo Fisher Scientific (Waltham, MA). The ddPCR assay was
performed in triplicate on DNA from four samples (fetal, maternal and
paternal blood, and paternal sperm) using a BioRad QX200 instrument.
3 | RESULTS
3.1 | Family presentation
The proband (II.3) is a one-day old deceased female infant with syn-
dromic CAKUT (Figure 1a). Her nonconsanguineous healthy parents
have no family history of CAKUT. However, the father had an ultra-
sound in childhood which demonstrated subclinical dilation of one
renal pelvis in an otherwise normal urinary tract. He has had no renal-
related illnesses during his adult life.
The couple's firstborn, a 5-year-old healthy female, was antenatally
diagnosed with an ovarian cyst but did not show any renal anomalies on
abdominal ultrasound. Their second pregnancy resulted in a miscarriage
before 12 weeks' gestation for which no genetic testing was performed.
The proband was born following their third pregnancy in which a
mildly increased nuchal translucency (3.0 mm) and polyhydramnios
were noted at 12 weeks' gestation. Early morphology ultrasound
(16 weeks) identified hypoplastic lungs, dilated bilateral renal pelves,
a horseshoe kidney, small abdominal and chest circumferences, an
apparent left-sided diaphragmatic hernia, and confirmed poly-
hydramnios. The couple was counseled regarding aneuploidy risk but
opted to forego invasive testing and continued the pregnancy. The
female infant was born via elective cesarean section at 38 weeks' ges-
tation (birthweight 2,920 g). After delivery, the infant required
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ventilatory support for severe persistent pulmonary hypertension sec-
ondary to pulmonary hypoplasia but deteriorated over 24 hours
and died.
Karyotype of the female proband was normal (46, XX) and microar-
ray analysis (Illumina CytoSNP-850 k) did not identify any CNVs.
At autopsy, external examination revealed mildly dysmorphic facial fea-
tures including hypertelorism, a prominent forehead, and a protuberant
tongue (Figure 1b). In addition, overlapping 3–4 fingers (right hand) and
1–2 toes (right foot) were noted. Internal examination showed severe
pulmonary hypoplasia associated with a markedly thinned (transparent)
diaphragm leading to eventration without true diaphragmatic hernia
(Figure 1d). Other findings included asplenia, a horseshoe kidney with
bilateral pelvic dilatation, abnormal ureter insertion into the bladder,
and a bicornuate uterus (Figure 1c). The placenta was small for gesta-
tional age (weight 361 g [NR 2SD 409–589 g]).
Histology showed immature development of the lung, consistent
with a congenital alveolar dysplastic pattern. There were thick septa and
excessive vessels. Hyaline membranes were seen throughout the lung.
Bronchi were correctly positioned and veins were present in the septum,
making capillary alveolar dysplasia unlikely. There was marked reduction
in the radial alveoli count with some areas showing minimal alveolar tis-
sue between the bronchial and the lung wall. Immunohistochemical
stains for cytokeratins and vascular markers were used to further detail
the structure of the hypoplastic lungs. The hypoplastic lungs were
thought to best represent a congenital alveolar dysplastic pattern.
Along with the structural abnormalities, there was a dense neutrophil
infiltrate present within the alveoli spaces, consistent with pneumonia.
The fourth pregnancy of the couple was uncomplicated and
resulted in the birth of a healthy female who was confirmed negative
for the familial PBX1 mutation.
The couple naturally conceived a fifth pregnancy (II.5). The 12-week
ultrasound scan showed normal nuchal translucency but limited other
information. Prenatal diagnosis at 11 weeks' gestation showed a 46, XY
karyotype and revealed the presence of the PBX1 mutation. A 16-week
F IGURE 1 (a) Pedigree, (b–d) Autopsy photographs of the proband (II-3). (b) Dysmorphic features include hypertelorism, prominent forehead, and
downturn corners of the mouth. (c) Horseshoe kidney. (d) Extremely thin, transparent diaphragm (white arrow). (e–j) Autopsy photographs and histology
images of the affected sibling (II-5), (e) Dysmorphic features include deep-set eyes and prominent forehead. Note normal female genitalia despite 46, XY
karyotype. (f) Hypoplastic spleen (white arrow) and tiny accessory spleen (white arrowhead). (g) Paper-thin diaphragm with forceps visible through
diaphragm (white arrow). (h) Macroscopically normal ovary (white arrow), fallopian tube (white arrowhead), and uterus (†). (i) Histology of diaphragm
demonstrating complete absence of muscle cells (white arrow). (j) Normal histology of fallopian tube (white arrow) and ovary (white arrowhead)
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early morphology ultrasound showed a dilated renal pelvis and possible
small diaphragmatic hernia. A follow-up (20-week) ultrasound revealed a
ventricular septal defect, an overriding aorta, possible pulmonary atresia,
bilateral renal pelvis dilatation, and ambiguous genitalia. The diaphrag-
matic hernia was not confirmed. Decreased fetal movements were noted
at 35 weeks and the mother presented with a stillbirth shortly after.
Autopsy demonstrated marked thinning/aplasia of the diaphragm leading
to eventration, normal female appearing external genitalia with a nor-
mally formed vagina, uterus, fallopian tubes and ovaries, a small spleen
and smaller accessory spleen, bilaterally small kidneys and bilateral ure-
teric dilatation, a bell-shaped chest, and pulmonary hypoplasia
(Figure 1e–j). A precise cause of death was not identified at autopsy;
however, multiple congenital anomalies and congenital heart disease are
both separately associated with an increased risk of stillbirth (Liu et al.,
2019; Mcclure et al., 2015). Autopsy identified some subtle placental
abnormalities including subchorionitis, early choriodeciduitis, and a small
localized infarct but these findings were not considered causative of still-
birth as they are relatively nonspecific common findings. Given the dis-
cordant chromosomal (46, XY) and phenotypic sex, the karyotype was
checked on a separate sample, and was again confirmed as 46, XY.
3.2 | Genomic analysis
Filtering for rare, nonsynonymous variants in the proband (II.3)
yielded high quality variants affecting one AD and three AR genes
(Table S2). Further prioritization for genes associated with renal
disorders highlighted one AD de novo variant; a missense variant
in PBX1 (Chr1(hg19):g.164761784C > T; NM_002585.3:c.319C > T;
NP_002576.1:p.(Arg107Trp)), that was absent from population data-
bases and not called in either parent. However, manual inspection
of sequencing reads showed the variant at low level (7%, 10/136 variant
reads; Figure S2) in the paternal blood sample. The PBX1 p.(Arg107Trp)
variant was predicted to be deleterious by multiple computational patho-
genicity predictors, such as CADD, SIFT, PolyPhen, and Mutation Taster
(Table S3). Follow-up by ddPCR revealed that the variant was present in
10.4% of paternal blood cells and 20.1% of sperm cells (Figure S3).
4 | DISCUSSION
PBX1 encodes the Pre-B Cell Leukemia Transcription Factor,
which regulates the expression of genes involved in tissue develop-
ment, including morphologic patterning and hematopoiesis (Ficara,
Murphy, Lin, & Cleary, 2008; Heidet et al., 2017; Slavotinek et al.,
2017; Le Tanno et al., 2017). Highlighting the importance of PBX1
in organogenesis, Pbx1−/− mice displaying asplenia, hyposplenia,
and diaphragmatic muscularization and tissue patterning defects
(Brendolan et al., 2005; Koss et al., 2012; Russell et al., 2012).
Here, we present paternal mosaicism for a PBX1 mutation
leading to perinatal death in two siblings, with the identified variant,
p.(Arg107Trp), underlying a severe presentation of the multisystem dis-
order caused by PBX1mutations. The congenital abnormalities observed
in our siblings expand the phenotypic spectrum of PBX1-associated dis-
ease with unique features including severe diaphragmatic eventration,
and asplenia/microsplenia. While unilateral diaphragmatic eventration
has been reported in two patients (Slavotinek et al., 2017), our patients'
diaphragms were entirely membranous and devoid of muscle tissue.
Genital abnormalities are commonly reported in male patients with
PBX1 mutations (10/14), with the phenotypic spectrum ranging from
cryptorchidism to partial development of female internal and/or external
genitalia (Alankarage et al., 2019; Eozenou et al., 2019; Kia et al., 2019;
Riedhammer et al., 2017; Slavotinek et al., 2017; Le Tanno et al., 2017).
Interestingly, the second affected sibling (II-5; 46, XY) presented here
showed complete sex reversal of both internal and external organs, with-
out any signs of male gonad development (no streak gonad). In line with
earlier reports (Eozenou et al., 2019; Slavotinek et al., 2017), the pheno-
typic heterogeneity among patients carrying the same mutation indicates
a limited genotype–phenotype correlation, possibly influenced by factors
such as gender, genetic modifiers, or skewed gene expression.
In recent years, the contribution of parental mosaicism to de novo
mutations has been reported for several (neuro-)developmental disorders
(Acuna-Hidalgo et al., 2015; Wright et al., 2019). However, potential
recurrence of presumed de novo mutations is still not routinely consid-
ered in research and diagnostics. Using ddPCR, the low-level paternal
mosaic PBX1 mutation was detected in 20.1% of sperm cells, indicating
an estimated recurrence risk of one in five. For this family, unfortunately,
their subsequent affected pregnancy was conceived before these results
were available and assisted reproductive options could be considered.
Altogether, we identified recurrence for a novel PBX1 mutation in
two siblings, leading to severe congenital abnormalities and perinatal
lethality. The severe diaphragmatic hypoplasia, asplenia/microsplenia
and complete sex reversal observed in our patients further expand the
clinical phenotypes associated with the PBX1-related complex multi-
system abnormality syndrome. In addition, this report also represents
the first mosaic PBX1 mutation in a parent leading to recurrence,
highlighting the relevance of follow-up screening.
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